Newron Pharmaceuticals SPA/ IT0004147952 /
2024-05-15 3:30:01 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
12.0000USD | - | 100 Turnover: 1,200 |
-Bid Size: - | -Ask Size: - | 198.57 mill.USD | - | - |
GlobeNewswire
2018-01-16
Parkinson's Disease Drugs Market, 2022: Levodopa Therapy, Dopamine Therapy, MAO-B Inhibitor Therapy,...
GlobeNewswire
2017-12-22
Saniona AB: The Nomination Committee of Saniona Proposes Election of Two Additional Members of the B...
GlobeNewswire
2011-10-21
Biotie informed that Merck Serono is returning full global rights for safinamide to Newron
GlobeNewswire
2011-10-05
Notice to Biotie shareholders on registration of merger plan and documents available for review